🛡️ Category
Peptides for Immune Support
Thymic peptides investigated for immune modulation and resilience, some used clinically outside the US.
Thymic peptides investigated for immune modulation and resilience, some used clinically outside the US.
Immune peptides span several distinct families. Thymic peptides (thymosin alpha-1, thymalin, thymopentin, thymogen, thymulin) are derived from or modeled on the thymus gland and are studied for modulating T-cell function — several are used clinically outside the US but remain unapproved domestically. Antimicrobial peptides like the human cathelicidin LL-37 are part of innate immunity, with a notable double-edged biology that also links them to inflammatory disease.
This category also contains two genuinely FDA-approved peptide drugs that work through immune-related mechanisms: icatibant (a bradykinin antagonist for hereditary angioedema) and glatiramer acetate (a polypeptide immunomodulator for multiple sclerosis) — useful reminders that "immune peptide" covers everything from unproven research chemicals to established medicines.
A naturally occurring thymic peptide that modulates immune function, approved in some countries (as Zadaxin) for hepatitis and as a vaccine adjuvant.
Read the guide →A thymus-derived peptide preparation studied — largely in Russia — for restoring immune balance and as part of peptide bioregulation research on aging.
Read the guide →The body's main cathelicidin antimicrobial peptide, central to innate immunity and wound healing — but with a complex, context-dependent (and sometimes harmful) biology.
Read the guide →A tripeptide fragment of α-MSH studied for anti-inflammatory effects, particularly in the gut and skin, without α-MSH's pigmentation activity.
Read the guide →A peptide derived from the tissue-protective region of erythropoietin (EPO) — without EPO's red-blood-cell effects — studied in trials for neuropathic pain and small-fiber neuropathy.
Read the guide →A simple synthetic dipeptide (glutamyl-tryptophan) developed in Russia as an immunomodulator, used there for immune support during infections.
Read the guide →A zinc-dependent thymic hormone (a nonapeptide) involved in T-cell maturation, studied for immune regulation, inflammation, and pain.
Read the guide →A synthetic pentapeptide corresponding to the active site of the thymic hormone thymopoietin, studied and marketed in some countries as an immunomodulator.
Read the guide →A bradykinin B2 receptor antagonist peptide, FDA-approved (as Firazyr) to treat acute attacks of hereditary angioedema.
Read the guide →A random polypeptide mixture of four amino acids and an FDA-approved immunomodulator (Copaxone) for relapsing-remitting multiple sclerosis.
Read the guide →A 28-amino-acid neuropeptide with vasodilatory, anti-inflammatory, and immune-regulating roles; its synthetic form (aviptadil) has been investigated for lung conditions such as ARDS.
Read the guide →A 36-amino-acid peptide and the first HIV fusion inhibitor (Fuzeon), FDA-approved to block HIV-1 from entering host cells in treatment-experienced patients.
Read the guide →A short dipeptide bioregulator (Lys-Glu) from the Khavinson research line, studied — largely in Russia — for immune and thymic regulation and aging.
Read the guide →The body's “master antioxidant” — a naturally occurring tripeptide central to cellular defense, studied for oxidative stress, immune function, metabolic health, and (controversially) skin lightening.
Read the guide →"Immune support" is a vague phrase, and it is worth replacing it with what these compounds actually target — because the immune system is not a dial that can be turned up.
Thymic peptides. The thymus trains T cells and shrinks progressively with age. Thymosin alpha-1, thymalin, thymogen and thymulin derive from that biology, aiming to restore thymic signalling. Thymosin alpha-1 has the strongest position of the group and is approved in a number of countries — though not the United States — for hepatitis B and as a vaccine adjuvant.
Antimicrobial peptides. LL-37 is part of the innate immune system's direct defence, disrupting bacterial membranes and modulating inflammatory signalling.
Anti-inflammatory peptides. KPV, a fragment of alpha-MSH, and ARA-290 aim to dampen inflammation rather than stimulate immunity — which is the opposite direction, and a good illustration of why "immune support" is too crude a description.
Approved immunomodulators. Glatiramer acetate for multiple sclerosis and enfuvirtide for HIV are genuine approved medicines that work through immune-related mechanisms, with full trial evidence behind them.
The marketing language around this category assumes that more immune activity is better. Immunology does not work that way, and the distinction matters for safety as much as for accuracy.
An immune system that is too active causes autoimmune disease, allergy and chronic inflammation — conditions in which the body attacks itself. An immune system that is too suppressed permits infection and cancer. What clinicians aim for is appropriate regulation, not maximum activation, which is why the field's term of art is immunomodulation.
This has a direct practical consequence. Non-specifically stimulating immune activity is not obviously desirable and may be actively harmful for anyone with an autoimmune condition, anyone on immunosuppressive therapy, or anyone who has had a transplant. A compound that genuinely stimulated immunity would be a drug requiring careful supervision, not a wellness product.
It is also worth noting how many of the popular compounds in this category are anti-inflammatory rather than stimulatory — KPV and ARA-290 both dampen immune signalling. They are marketed under the same "immune support" banner as thymic peptides that aim to do the reverse, which tells you how little that phrase constrains what a product actually does.
See immune peptides for a compound-by-compound assessment of what has actually been studied.
Thymosin alpha-1 is approved in a number of countries (as Zadaxin) for conditions like hepatitis and modulates T-cell function, but it is not FDA-approved in the US. Most other thymic peptides have limited independent evidence and are unapproved research compounds.
No. LL-37 is a natural human antimicrobial peptide, not an approved drug. Its biology is double-edged — it also contributes to inflammatory and autoimmune conditions — so it is a research subject rather than a supplement.
Icatibant (Firazyr), for acute hereditary angioedema attacks, and glatiramer acetate (Copaxone), for relapsing multiple sclerosis, are FDA-approved. Most other peptides in this category are not.